RK
Highly rated in
33
conditions
Highly rated in
33
conditions

Specialties:Oncology | Hematology | Internal Medicine
Experience:25 Years
Accepts:New PatientsMedicare
About Dr. Rami S. Komrokji

Rami Komrokji is an Oncologist and a Hematologist in Tampa, Florida. Dr. Komrokji has been practicing medicine for over 25 years and is highly rated in 33 conditions, according to our data. His top areas of expertise are Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Leukemia, and Acute Myeloid Leukemia. He is board certified in Hematology/oncology and Internal Medicine and licensed to treat patients in Ohio. Dr. Komrokji is currently accepting new patients.

His clinical research consists of co-authoring 260 peer reviewed articles and participating in 72 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Rami S. Komrokji it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Call Now
Locations
  12902 Usf Magnolia Dr Tampa, FL 33612, US
Background & Education
Specialties
Oncology
Hematology
Internal Medicine
Licenses
Internal Medicine in OH
Board Certifications
Hematology/oncology
Internal Medicine
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


16 Clinical Trials


Recruiting
Enrollment Status:Recruiting
Study Type:Drug, Biological
Study Phase: Phase 1/Phase 2
CD8 Depleted, Non-Engrafting, HLA Mismatched Unrelated Donor Lymphocyte Infusion in Patients With MDA and Secondary AML
View Trial




Recruiting
Enrollment Status:Recruiting
Study Type:Drug
Study Phase: Phase 1
Phase 1/1b Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
View Trial


View 9 More Clinical Trials +

260 Total Publications

Journal: Expert opinion on emerging drugs
Published —June 18, 2021
Stepping out of antiquity: An update on emerging drugs for the treatment of polycythemia vera.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
Hematology | Oncology | Internal Medicine
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
12902 Usf Magnolia Dr
 
Tampa, FL 33612
 0.1 mi
Jeffrey Lancet is a Hematologist and an Internal Medicine specialist in Tampa, Florida. He has been an author on 162 peer reviewed articles and participated in 96 clinical trials in the past 15 years. He is licensed to treat patients in FL.
Highly rated in
0
conditions
Hematology | Oncology | Internal Medicine
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
12902 Usf Magnolia Dr
 
Tampa, FL 33612
 0.1 mi
Jonathan Strosberg is an Internal Medicine specialist and a Hematologist in Tampa, Florida. He has been an author on 175 peer reviewed articles and participated in 101 clinical trials in the past 15 years. He is licensed to treat patients in FL.
Highly rated in
0
conditions
Hematology | Oncology | Internal Medicine
H. Lee Moffitt Cancer Center & Research Institute
12902 Usf Magnolia Dr
 
Tampa, FL 33612
 0.1 mi
Alan List is a Hematologist and an Internal Medicine specialist in Tampa, Florida. He has been an author on 279 peer reviewed articles and participated in 30 clinical trials in the past 15 years. He is licensed to treat patients in FL.